Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aslan Pharmaceuticals Ltd ADR (NQ: ASLN )

2.740 +0.040 (+1.48%)
Streaming Delayed Price Updated: 3:59 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 63,106
Open 2.700
Bid (Size) 2.650 (1)
Ask (Size) 2.740 (1)
Prev. Close 2.700
Today's Range 2.650 - 2.900
52wk Range 1.702 - 4.945
Shares Outstanding 402,116,835
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ASLAN Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire

Performance

YTD
+25.92%
+25.92%
1 Month
-30.54%
-30.54%
3 Month
+40.48%
+40.48%
6 Month
-9.42%
-9.42%
1 Year
-38.62%
-38.62%

More News

Read More
ASLAN Pharmaceuticals to Participate in Fireside Chat at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
10 Short Squeeze Candidates: PaxMedica, Blue Apron, MicroStrategy And More
Via Benzinga
ASLAN Pharmaceuticals Announces Acceptance of Two Abstracts for Poster Presentation at the 1st International Societies for Investigative Dermatology Meeting
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
ASLAN Pharmaceuticals to Host Virtual Research and Development Day on Novel DHODH Inhibitor Farudodstat for Alopecia Areata
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
ASLAN Pharmaceuticals to Advance Novel DHODH Inhibitor Farudodstat Into Phase 2 Clinical Testing as Potential First-In-Class Treatment for Alopecia Areata
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
ASLAN Pharmaceuticals Announces $20M Private Placement Led by BVF Partners L.P. With the Potential to Receive Up to an Additional $80M
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
ASLAN Pharmaceuticals Announces Completion of Recruitment in Phase 2b TREK-AD Study of Eblasakimab in Atopic Dermatitis Patients
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
ASLAN Pharmaceuticals and Thermo Fisher Scientific Announce Partnership to Manufacture High Concentration Formulation of Eblasakimab for Future Studies
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
ASLAN Pharmaceuticals Announces Participation in January Investor Conferences
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
ASLAN Pharmaceuticals Announces First Patient Screened in Study of Eblasakimab in Dupilumab Experienced Atopic Dermatitis Patients
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
ASLAN Pharmaceuticals to Participate in a Fireside Chat at 34th Annual Piper Sandler Healthcare Conference
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
ASLAN Pharmaceuticals to Participate in Jefferies London Healthcare Conference
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
ASLAN Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From ASLAN PHARMACEUTICALS LIMITED
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.